Eventide Asset Management, LLC Macrogenics Inc Transaction History

Eventide Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 21, 2019	SELL	$12.44 - $17.48 $6.03 Million - $8.48 Million	-485,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $5.39 Million - $12.4 Million	485,000 New	485,000 $8.72 Million
Q4 2018 Feb 14, 2019	SELL	$11.75 - $21.42 $1.73 Million - $3.15 Million	-147,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $2.28 Million - $2.78 Million	147,000	147,000 $2.72 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $210M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.